Willingness and Ability to Use TRIPs Flexibilities: Kenya case study

HSRC REPORT: This study describes the current context relating to access to medicines in Kenya , which currently obtains medicines from domestic and international sources. It also outlines the influence of TRIPS on availability of essential medicines in health centers in Kenya. It looks at how TRIPS flexibilities influence the importation of specific drugs and… Read more

A Survey of Policy and Practice on the use of access to Medicines- Related TRIPs flexibilities in Malawi

HSRC REPORT: This study describes the current context relating to access to medicines in Malawi, including sources of supply and relevant existing legislation. It outlines future access scenarios, and suggests that current political will be capitalised upon and key ministries and institutions be supported in their access to medicines-related and broader TRIPs-related initiatives.

Processes and issues for improving access to medicines: Willingness and ability to utilise TRIPS flexibilities in non-producing countries

HSRC REPORT: This paper addresses varied ways by which a non-producing country may lawfully utilise TRIPS flexibilities, and looks at the internal and external forces which negatively affect non-producing countries’ ability and willingness to use TRIPS-compliant flexibilities.  

The Effect of Changing Intellectual Property on Pharmaceutical Industry Prospects in India and China: Considerations for Access to Medicines

HSRC REPORT: This study considers: how is the implementation of product patents in India and China affecting access to medicines; will generic copies of patented medicines have to be withdrawn from the market; will prices rise; will the domestic industry disappear; and will MNCs (Multi-national Corporations) become more interested in working with domestic firms, including… Read more

Emerging Challenges and Opportunities in Drug Registration and Regulation in Developing Countries

HSRC REPORT: This study describes current drug regulation and registration processes in selected countries in order to understand how they affect the quality and availability of medicines in developing countries, develops policy recommendations as to how systems can more efficiently allow appropriate quality drugs to market, and discusses emerging challenges and requirements posed by compulsory… Read more

Provision of antiretroviral therapy in resource-limited settings: a review of experience up to August 2003

HSRC REPORT: This paper aims to increase understanding of the requirements for introducing and scaling up provision of Anti-retroviral Therapy (ART) as part of comprehensive HIV/AIDS programmes in resource-poor countries. It explores the feasibility of ART in resource poor settings;the different approaches taken to the delievery of ART; the issues to be considered in scaling… Read more

Page 4 of 41234